Flumazenil Injection, Solution
Product Images NDC 51662-1253

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (10 mL Vial Label)

FLUMAZENIL injection, USP label for 1 mg/10 mL (0.1 mg/mL) intravenous injection solution. This 10 mL multiple dose vial is sterile, for IV use only, and RX only. The label lists composition details, storage instructions, and manufacturing information from HIKMA Farmacêutica (Portugal) with distribution by West-Ward Pharmaceutical Corp. in Eatontown, NJ.*

FDA Label Image

Serialized Label (51662 1253 1 Flumazenil 10 Serialized Label)

Flumazenil injection, solution in a clear glass vial with a green cap. The label indicates a strength of 1 mg per 10 mL (0.1 mg/mL) for intravenous use. The vial is distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label includes a 2D barcode and regulatory codes.*

FDA Label Image

Tabel (Clinica Pharma Tabel)

A data table summarizing pharmacokinetic parameters including Cmax (ng/mL), AUC (ng·hr/mL), Vss (L/kg), Cl (L/hr/kg), and half-life (min) with mean values and ranges or variability percentages for each parameter.*

FDA Label Image

Chart (Clinical Pharma Chart)

A graph depicting the magnitude and duration of sedation reversal after intravenous Flumazenil injection at doses of 0.2, 0.6, and 1 mg. The y-axis shows alertness levels which include sedated, baseline sedation, awake, and completely alert states, while the x-axis indicates minutes after Flumazenil injection. The graph illustrates decreasing sedation over time, varying by dose, with higher doses leading to quicker reversal.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Flumazenil, showing its molecular arrangement with marked atoms and bonds typical of this active ingredient.*

FDA Label Image

Warning Box (Warnings Box)

A text panel warning that the use of Flumazenil has been associated with seizures, especially in patients on long-term benzodiazepines or with serious cyclic antidepressant overdose. It advises practitioners to individualize dosage and be prepared to manage seizures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.